BrainChip (BRN) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
19 Oct, 2025Market opportunity and growth
Edge AI market projected to grow from $6B in 2023 to $84B by 2030, with a 34% CAGR.
GenAI and Edge LLMs are emerging as significant segments, with Edge LLMs forecasted at a 28.3% CAGR.
All edge AI market segments, including consumer electronics, IT/telecom, automotive, healthcare, and industrial, are expected to see 20% CAGR through 2030.
Target use cases include defense, medical, industrial, and consumer sectors, focusing on large addressable markets.
6B embedded microcontrollers are forecasted to use AI/ML by 2030, with a 30% MPU attach rate.
Technology and product portfolio
Akida platform offers configurable IP, chips, boards, subsystems, and reference solutions for on-device AI acceleration.
Neuromorphic processing enables ultra-low power event-based computing, ideal for edge applications.
Product releases include partnerships for AI-powered wearables, radar, and event-based vision solutions.
AKD1500 product targets integration in defense, industrial, healthcare, and consumer devices, with <1 watt AI co-processor.
Flexible licensing model covers IP, software, chip designs, and cloud enablement.
Strategic partnerships and ecosystem
Collaborations with industry leaders such as Raytheon, Renesas, Airbus, NASA, Mercedes-Benz, and GlobalFoundries.
University partnerships include Arizona State, Carnegie Mellon, Cornell Tech, and others.
Ecosystem partners span hardware, software, and research, supporting customized solutions and reference designs.
Announced product collaborations with AFRL, Frontgrade Gaisler, Prophesee, and Andes.
Latest events from BrainChip
- Revenue up 374%, net loss reduced, and $37M raised to accelerate neuromorphic AI growth.BRN
H2 202526 Feb 2026 - Revenue up 72% and net loss reduced, with strong capital raises and key commercial wins.BRN
H2 202420 Feb 2026 - Cash position strengthened and new partnerships drive momentum for neuromorphic AI products.BRN
Q4 202529 Jan 2026 - Cash balance rose to $13.9M as AKD1500 enters volume production, backed by new capital and partnerships.BRN
Q3 20251 Dec 2025 - A pivotal year with a new product roadmap, higher bookings targets, and focus on shareholder alignment.BRN
AGM 202520 Nov 2025 - $35M placement and $2M SPP to accelerate edge AI commercialization and product expansion.BRN
Investor Presentation10 Nov 2025 - Revenue soared 859% and net loss narrowed, with new funding and partnerships fueling growth.BRN
H1 202521 Aug 2025 - Customer receipts surged and cash burn improved, supporting ongoing growth and innovation.BRN
Q2 202529 Jul 2025 - Cash position strengthened to US$25.6M, supporting commercialization and product development.BRN
Q3 202413 Jun 2025